Atrial myxoma mimicking systemic disease. Profile modified by flurbiprofen administration

Chest. 1996 May;109(5):1400-1. doi: 10.1378/chest.109.5.1400.

Abstract

A patient had a left atrial myxoma which was modified by flurbiprofen administration. The diagnosis was made 42 months after the first symptoms appeared. Flurbiprofen may have reduced interleukin-6 secretion by the tumor, leading to a delayed diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Arthralgia / drug therapy
  • Diagnostic Errors
  • Female
  • Flurbiprofen / therapeutic use*
  • Heart Neoplasms / diagnosis*
  • Heart Neoplasms / metabolism
  • Humans
  • Interleukin-6 / metabolism
  • Middle Aged
  • Muscular Diseases / drug therapy
  • Myxoma / diagnosis*
  • Myxoma / metabolism
  • Pain / drug therapy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Interleukin-6
  • Flurbiprofen